RCW 69.50.206
Schedule II.
(a) The drugs and other substances listed in this section, by whatever official name, common or usual name, chemical name, or brand name designated, are included in Schedule II.
(b) Substances. (Vegetable origin or chemical synthesis.) Unless specifically excepted, any of the following substances, except those listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:
(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and their respective salts, but including the following:
(i) Raw opium;
(ii) Opium extracts;
(iii) Opium fluid;
(iv) Powdered opium;
(v) Granulated opium;
(vi) Tincture of opium;
(vii) Codeine;
(viii) Dihydroetorphine;
(ix) Ethylmorphine;
(x) Etorphine hydrochloride;
(xi) Hydrocodone;
(xii) Hydromorphone;
(xiii) Metopon;
(xiv) Morphine;
(xv) Oripavine;
(xvi) Oxycodone;
(xvii) Oxymorphone; and
(xviii) Thebaine.
(2) Any salt, compound, isomer, derivative, or preparation thereof that is chemically equivalent or identical with any of the substances referred to in subsection (b)(1) of this section, but not including the isoquinoline alkaloids of opium.
(3) Opium poppy and poppy straw.
(4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves including cocaine and ecgonine, and their salts, isomers, derivatives, and salts of isomers and derivatives, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine.
(5) Concentrate of poppy straw (The crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.)
(c) Opiates. Unless specifically excepted or unless in another schedule, any of the following synthetic opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:
(1) Alfentanil;
(2) Alphaprodine;
(3) Anileridine;
(4) Bezitramide;
(5) Bulk dextropropoxyphene (nondosage forms);
(6) Carfentanil;
(7) Dihydrocodeine;
(8) Diphenoxylate;
(9) Fentanyl;
(10) Isomethadone;
(11) Levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
(12) Levomethorphan;
(13) Levorphanol;
(14) Metazocine;
(15) Methadone;
(16) Methadone—Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
(17) Moramide—Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;
(18) Pethidine (meperidine);
(19) Pethidine—Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
(20) Pethidine—Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
(21) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
(22) Phenazocine;
(23) Piminodine;
(24) Racemethorphan;
(25) Racemorphan;
(26) Remifentanil;
(27) Sufentanil;
(28) Tapentadol.
(d) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:
(1) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
(2) Methamphetamine, its salts, isomers, and salts of its isomers;
(3) Phenmetrazine and its salts;
(4) Methylphenidate;
(5) Lisdexamfetamine, its salts, isomers, and salts of its isomers.
(e) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) Amobarbital;
(2) Glutethimide;
(3) Pentobarbital;
(4) Phencyclidine;
(5) Secobarbital.
(f) Hallucinogenic substances.
Nabilone: Some trade or other names are ( ± )-trans3-(1,1-dimethlheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzol[b,d]pyran-9-one.
(g) Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
(1) Immediate precursor to amphetamine and methamphetamine:
(i) Phenylacetone: Some trade or other names phenyl-2-propanone, P2P, benzyl methyl ketone, methyl benzyl ketone.
(2) Immediate precursors to phencyclidine (PCP):
(i) 1-phenylcyclohexylamine;
(ii) 1-piperidinocyclohexanecarbonitrile (PCC).
The controlled substances in this section may be added, rescheduled, or deleted as provided for in RCW 69.50.201.
[ 2010 c 177 § 3; 1993 c 187 § 6; 1986 c 124 § 4; 1980 c 138 § 2; 1971 ex.s. c 308 § 69.50.206.]
NOTES:
Pharmacy quality assurance commission may change schedules of controlled substances: RCW 69.50.201.
Structure Revised Code of Washington
Title 69 - Food, Drugs, Cosmetics, and Poisons
Chapter 69.50 - Uniform Controlled Substances Act.
69.50.102 - Drug paraphernalia—Definitions.
69.50.201 - Enforcement of chapter—Authority to change schedules of controlled substances.
69.50.205 - Schedule II tests.
69.50.207 - Schedule III tests.
69.50.209 - Schedule IV tests.
69.50.213 - Republishing of schedules.
69.50.214 - Controlled substance analog.
69.50.302 - Registration requirements.
69.50.305 - Procedure for denial, suspension, or revocation of registration.
69.50.306 - Records of registrants.
69.50.311 - Triplicate prescription form program—Compliance by health care practitioners.
69.50.315 - Medical assistance—Drug-related overdose—Prosecution for possession.
69.50.317 - Opioid drugs—Communication with patient.
69.50.325 - Cannabis producer's license, cannabis processor's license, cannabis retailer's license.
69.50.327 - Cannabis processors—Incorporation of characterizing flavor in vapor products.
69.50.331 - Application for license.
69.50.334 - Denial of application—Opportunity for hearing.
69.50.335 - Cannabis retailer licenses—Social equity applicants—Rules—Definitions.
69.50.336 - Social equity in cannabis task force.
69.50.342 - State liquor and cannabis board—Rules.
69.50.345 - State liquor and cannabis board—Rules—Procedures and criteria.
69.50.346 - Labels on retail products.
69.50.348 - Representative samples of cannabis, useable cannabis, or cannabis-infused products.
69.50.351 - Board members and employees—Conflict of interest.
69.50.354 - Retail outlet licenses.
69.50.357 - Retail outlets—Rules.
69.50.363 - Cannabis processors, employees—Certain acts not criminal or civil offenses.
69.50.366 - Cannabis producers, employees—Certain acts not criminal or civil offenses.
69.50.369 - Cannabis producers, processors, researchers, retailers—Advertisements—Rules—Penalty.
69.50.372 - Cannabis research license.
69.50.375 - Cannabis retailers—Medical cannabis endorsement.
69.50.378 - Cannabis retailer holding medical cannabis endorsement—THC concentration in products.
69.50.385 - Common carriers—Licensing—State liquor and cannabis board to adopt rules.
69.50.395 - Licensed cannabis businesses, agreements—Disclosure to state liquor and cannabis board.
69.50.401 - Prohibited acts: A—Penalties.
69.50.4011 - Counterfeit substances—Penalties.
69.50.4012 - Delivery of substance in lieu of controlled substance—Penalty.
69.50.4014 - Possession of forty grams or less of cannabis—Penalty.
69.50.4015 - Involving a person under eighteen in unlawful controlled substance transaction—Penalty.
69.50.4016 - Provisions not applicable to offenses under RCW 69.50.410.
69.50.402 - Prohibited acts: B—Penalties.
69.50.403 - Prohibited acts: C—Penalties.
69.50.404 - Penalties under other laws.
69.50.405 - Bar to prosecution.
69.50.406 - Distribution to persons under age eighteen.
69.50.408 - Second or subsequent offenses.
69.50.410 - Prohibited acts: D—Penalties.
69.50.412 - Prohibited acts: E—Penalties.
69.50.4121 - Drug paraphernalia—Selling or giving—Penalty.
69.50.413 - Health care practitioners—Suspension of license for violation of chapter.
69.50.414 - Sale or transfer of controlled substance to minor—Cause of action by parent—Damages.
69.50.415 - Controlled substances homicide—Penalty.
69.50.416 - Counterfeit substances prohibited—Penalties.
69.50.420 - Violations—Juvenile driving privileges.
69.50.430 - Additional fine for certain felony violations.
69.50.438 - Cathinone or methcathinone—Additional fine.
69.50.440 - Possession with intent to manufacture—Penalty.
69.50.450 - Butane or other explosive gases.
69.50.455 - Synthetic cannabinoids—Unfair or deceptive practice under RCW 19.86.020.
69.50.460 - Cathinone or methcathinone—Unfair or deceptive practice under RCW 19.86.020.
69.50.465 - Conducting or maintaining cannabis club—Penalty.
69.50.470 - Medication disposal, no penalty for compliance.
69.50.475 - Cannabis retail outlets—Sale to persons under the age of twenty-one—Penalty.
69.50.500 - Powers of enforcement personnel.
69.50.501 - Administrative inspections.
69.50.502 - Warrants for administrative inspections.
69.50.504 - Cooperative arrangements.
69.50.505 - Seizure and forfeiture.
69.50.506 - Burden of proof; liabilities.
69.50.508 - Education and research.
69.50.509 - Search and seizure of controlled substances.
69.50.510 - Search and seizure at rental premises—Notification of landlord.
69.50.511 - Cleanup of hazardous substances at illegal drug manufacturing facility—Rules.
69.50.515 - Pharmacies—Cannabis—Notification and disposal.
69.50.525 - Diversion prevention and control—Report.
69.50.530 - Dedicated cannabis account (as amended by 2022 c 16).
69.50.540 - Dedicated cannabis account—Appropriations (as amended by 2022 c 16).
69.50.550 - Cost-benefit evaluations.
69.50.561 - Advice and consultation services—Licensed cannabis businesses.
69.50.563 - Licensed cannabis businesses—Civil penalty—Rules.
69.50.564 - Licensed cannabis businesses—Settlement agreement.
69.50.570 - Bundled transactions—Retail sales—Subject to tax—Exception.
69.50.575 - Cannabis health and beauty aids.
69.50.585 - Branded promotional items—Nominal value—Personal services.
69.50.587 - Cannabis science task force reports—Board rules.
69.50.601 - Pending proceedings.
69.50.602 - Continuation of rules.
69.50.603 - Uniformity of interpretation.